Angiogenesis in cutaneous malignant melanoma and potential therapeutic strategies. - Wikidata - awgldk - TriplyDB

Angiogenesis in cutaneous malignant melanoma and potential therapeutic strategies.

Angiogenesis in cutaneous malignant melanoma and potential therapeutic strategies.

http://www.wikidata.org/entity/Q37628695

about

Dual VEGF/VEGFR inhibition in advanced solid malignancies: clinical effects and pharmacodynamic biomarkers Targeting angiogenesis in melanoma: prospects for the future Angiogenesis and melanoma - from basic science to clinical trials.A phase I study of E7080, a multitargeted tyrosine kinase inhibitor, in patients with advanced solid tumours Intertumor heterogeneity in vascularity and invasiveness of artificial melanoma brain metastases.Phase I Dose-Escalation Study of the Multikinase Inhibitor Lenvatinib in Patients with Advanced Solid Tumors and in an Expanded Cohort of Patients with Melanoma.Blood vessel maturation, vascular phenotype and angiogenic potential in malignant melanoma: one step forward for overcoming anti-angiogenic drug resistance?'Malignant melanoma microecosystem': Immunohistopathological insights into the stromal cell phenotype.Melanomas prevent endothelial cell death under restrictive culture conditions by signaling through AKT and p38 MAPK/ ERK-1/2 cascades.In vitro and in vivo effects of an anti-mouse endoglin (CD105)-immunotoxin on the early stages of mouse B16MEL4A5 melanoma tumours.Malignant melanoma and its stromal nonimmune microecosystem.

P2860

Q33415397-7250AE50-15DE-48B4-8718-1F8289F02D94 Q35076316-9C972774-0975-4060-835F-F157FEF0C459 Q35380959-554B6617-709E-46B5-8DFC-BAFAC5A4EBF4 Q35949539-DEA2144D-7A05-47A1-B4E0-6557F305787B Q36370362-E51F1CEC-0166-4E4C-BFB6-E5CFA78FF1D7 Q36825455-6D97F24F-2E29-4951-9A9E-82C8A7142346 Q37846342-860AB464-AFC8-4FC8-ABFC-E135235B575B Q38043457-0FC8492C-FFFE-40FF-B9AF-4F4C1259823E Q39181848-1CEF9EB4-AAEE-4E03-A262-EC8F517BAA31 Q39257411-BD616FFA-5EDE-40B8-99C2-8E656E872DA4 Q42234458-1121A1C8-77AC-424B-AC20-D5344C910538

P2860

Angiogenesis in cutaneous malignant melanoma and potential therapeutic strategies.

http://www.wikidata.org/entity/Q37628695

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Angiogenesis in cutaneous malignant melanoma and potential therapeutic strategies.

@en

Angiogenesis in cutaneous malignant melanoma and potential therapeutic strategies.

@nl

type

label

Angiogenesis in cutaneous malignant melanoma and potential therapeutic strategies.

@en

Angiogenesis in cutaneous malignant melanoma and potential therapeutic strategies.

@nl

prefLabel

Angiogenesis in cutaneous malignant melanoma and potential therapeutic strategies.

@en

Angiogenesis in cutaneous malignant melanoma and potential therapeutic strategies.

@nl

P1433

Q37628695-0E66CD29-8DCA-4478-99D4-E1D5D1DD0620

P1476

Q37628695-B60842D3-12A5-4771-AF12-59B0EBA86AE2

P2093

Q37628695-12C078B5-B6B5-4A90-A6E3-F08E444A8F9C

Q37628695-2A055182-528E-4DCD-A348-9A9E56D1E537

Q37628695-484CDFEF-A494-43FF-894A-C9B13ED259CE

Q37628695-83446367-9FC2-4D19-9D78-18366ECD68C1

Q37628695-8654992F-200B-4AAE-ACB4-D63AFFA06065

P2860

Q37628695-0208F308-A591-41EB-93C5-4AF94ADF6682

Q37628695-03BF14B6-0847-4706-9145-810E7A65DD24

Q37628695-0506D2FC-B43A-4A78-B62C-67117AD74A58

Q37628695-09CC4FA7-4F43-46D2-BD86-6CD4F16289B6

Q37628695-09F91EA0-334A-4437-A97D-50212604BC84

Q37628695-0D37F87B-96F5-4623-BA54-50F38F2854E1

Q37628695-0FB24AA8-753C-431F-9879-C7913B00E515

Q37628695-11599007-FB83-4370-8EB7-875882308277

Q37628695-1801DE13-9D0A-4092-88ED-5F5F0CFDEEBD

Q37628695-1B93A2A0-81A6-4CDF-AC34-84145B25FE83

P304

Q37628695-258E407E-0FD9-4712-9B2F-58EBBF96B1D4

P31

Q37628695-98183F8C-D785-4FB9-B5E4-B0F6D34576BF

P356

Q37628695-9E65A710-0DFB-4F7C-AEB8-62EDA0F04AF9

P433

Q37628695-5FCC60E3-52AF-434C-9586-68BDCB702B36

P478

Q37628695-BBAE93A8-C55C-4880-A224-19958C6E6AD7

P577

Q37628695-9A15070D-4B3A-4636-8540-867949F7B30C

P5875

Q37628695-2F12A19F-1667-440F-855D-0F68250C584E

P698

Q37628695-E32ED946-A5B1-442C-A439-350CE5BE0424

P356

P1433

Expert Review of Anticancer Therapy

P1476

Angiogenesis in cutaneous malignant melanoma and potential therapeutic strategies.

@en

P2093

Bhawna Sirohi

http://www.w3.org/2001/XMLSchema#string

Bristi Basu

http://www.w3.org/2001/XMLSchema#string

Jessica Wrigley

http://www.w3.org/2001/XMLSchema#string

Pippa Corrie

http://www.w3.org/2001/XMLSchema#string

Swethajit Biswas

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

Genes expressed in human tumor endothelium

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

Integrin alphavbeta3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis

Demonstration of a genetic therapeutic index for tumors expressing oncogenic BRAF by the kinase inhibitor SB-590885

Tumor angiogenesis: therapeutic implications

The biology of VEGF and its receptors

Mutations of the BRAF gene in human cancer

P304

1583-1598

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERA.09.135

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2009-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38072580

http://www.w3.org/2001/XMLSchema#string

P698

19895243

http://www.w3.org/2001/XMLSchema#string